Blog

Clinical Trials Central Laboratories Infectious Diseases

March 5, 2019 Ayaskant Pany, MD

Studying infectious disease in remote villages

Authors: Dr. Ayaskant Pany, Sorika Van Niekerk, Johan Venter, Nuria Martinez-Alier, Viola-Marie RaubenheimerIncreased global travel means that infectious disease outbreaks are spreading faster and...

Infectious Diseases Vaccines

March 5, 2018 Ayaskant Pany, MD

Laboratory Expertise for Early Bactericidal Activity (EBA) Studies

Authors: Dr. Ayaskant Pany and Sorika Van NiekerkRead somewhere recently: “What is the biggest constraint for tuberculosis (TB) clinical trials? RESOURCES!” This is so true not only in the...

Infectious Diseases Vaccines

March 8, 2017 Ayaskant Pany, MD

What Does the Global Tuberculosis Biopharmaceutical Market Need to Grow?

Despite significant annual variation in research funding and global funding totals that fall far short of the field’s reported needs, the global market in tuberculosis (TB) diagnostics and treatments...

Infectious Diseases Vaccines

March 7, 2017 Ayaskant Pany, MD

A Super Battle Against Superbugs: Developing an Effective Drug-Resistant Tuberculosis Research Strategy

When most people think of emerging threats to public health, tuberculosis (TB) is unlikely to rise to the forefront of their minds. After all, TB has a long history and has been a well-known global...

Central Laboratories Infectious Diseases Vaccines

March 24, 2016 Ayaskant Pany, MD

Waging War of TB

Despite the fact that tuberculosis (TB) has been curable, it has become a global epidemic that impacts more people every year than HIV/AIDS. The millions of TB patients worldwide suffer from...

Filter By Topic

Search Blog Articles

Studying infectious disease in remote villages

Laboratory Expertise for Early Bactericidal Activity (EBA) Studies

What Does the Global Tuberculosis Biopharmaceutical Market Need to Grow?

A Super Battle Against Superbugs: Developing an Effective Drug-Resistant Tuberculosis Research Strategy

Waging War of TB